Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Soy lecithin is a food additive and dietary supplement derived from soybeans that functions primarily as an emulsifier. It contains a mixture of phospholipids, including phosphatidylcholine, phosphatidylinositol, and phosphatidylethanolamine, along with other components. Soy lecithin is a complex mixture of phospholipids, glycolipids, and triglycerides extracted from soybeans. It contains substantial amounts of phosphatidylcholines, phosphatidylethanolamines, and phosphatidylinositols[3]. The extraction process typically involves using a chemical solvent like hexane to extract oil from raw soybeans, followed by a degumming process that separates and dries the lecithin[4]. In the body, lecithin serves as the main dietary source of choline, a nutrient similar to B vitamins. This choline is converted into acetylcholine, a neurotransmitter essential for nerve impulse transmission[1][9]. The major components of commercial soybean-derived lecithin include: - 33-35% soybean oil - 20-21% phosphatidylinositols - 19-21% phosphatidylcholine - 8-20% phosphatidylethanolamine - 5-11% other phosphatides including phosphatidylserine - 5% free carbohydrates - 2-5% sterols - 1% moisture[5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Soy Lecithin.